Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Invitation Only

Ticketed - Complimentary

Ticketed - Additional Fee Required

Capturing for On Demand

Pharmacology

National Health Priorities

Potential State Requirement

Project Innovation

PA Administrative Competencies

104 Views

Favorite
Like
Facebook
Print

Learn about a nonhormonal FDA-approved treatment for moderate to severe vasomotor symptoms due to menopause

Tuesday, May 20, 2025

11:45 AM – 12:45 PM

Location: Colorado Convention Center, Mile High Ballroom 4

Audrey Fenwick, PA-C, MSCP

Women First of Louisville, Louisville, KY

In this session, we will review an FDA-approved treatment for moderate to severe vasomotor symptoms due to menopause, including indication, mechanism of action, and clinical safety and efficacy.

Brought to you by: Astellas Pharma US, Inc.